Meadow Creek Investment Management’s Charles River Laboratories CRL Stock Holding History

Meadow Creek Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.19M	Sell	8,960 -5,628	-39%	-$755K	0.02%	442
2019 Q2	$2.07M	Buy	14,588 +3,220	+28%	+$437K	0.04%	330
2019 Q1	$1.65M	Buy	11,368 +3,416	+43%	+$449K	0.03%	362
2018 Q4	$900K	Sell	7,952 -1,904	-19%	-$238K	0.02%	453
2018 Q3	$1.33M	Buy	9,856 +1,344	+16%	+$166K	0.03%	395
2018 Q2	$956K	Sell	8,512 -4,424	-34%	-$478K	0.02%	450
2018 Q1	$1.38M	Sell	12,936 -84	-0.6%	-$9.05K	0.03%	353
2017 Q4	$1.43M	Buy	13,020 +7,476	+135%	+$814K	0.03%	376
2017 Q3	$599K	Buy	5,544 +840	+18%	+$86.3K	0.01%	548
2017 Q2	$476K	Buy	4,704 +560	+14%	+$51.5K	0.01%	613
2017 Q1	$373K	Sell	4,144 -168	-4%	-$14.3K	0.01%	617
2016 Q4	$329K	Buy	+4,312	New	+$327K	0.01%	608

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Meadow Creek Investment Management's CRL Position: Q3 2019 in Review

Meadow Creek Investment Management reduced its Charles River Laboratories (CRL) stake by 39% in Q3 2019, selling an estimated $755K and leaving 8,960 shares worth $1.19M. The position accounts for 0.02% of the portfolio, ranked #442.

Meadow Creek Investment Management first reported a position in CRL in Q4 2016 and has held it in 12 quarters since. The position peaked at $2.07M in Q2 2019. 396 funds tracked by Wall St. Rank hold CRL as of Q3 2019.

Meadow Creek Investment Management held 8,960 shares of Charles River Laboratories worth $1.19M as of Q3 2019.
Meadow Creek Investment Management sold 5,628 Charles River Laboratories shares in Q3 2019, an estimated $755K.
Charles River Laboratories made up 0.02% of Meadow Creek Investment Management's portfolio in Q3 2019, its #442 holding.
Meadow Creek Investment Management first reported a position in Charles River Laboratories in Q4 2016 and has held it in 12 quarters since.
Meadow Creek Investment Management's Charles River Laboratories position peaked at $2.07M in Q2 2019.
396 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.